KCNIP3 and lung cancer: Recent in vivo studies have shown that clinically available drugs, such as cyclosporin A (CsA) and pitavastatin, can promote DREAM complex formation and induce the quiescent phase in lung cancer cells and in vivo lung cancer models [57].